News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2017

7 November, 2017 PledPharma appoints Yilmaz Mahshid as new CFO News English IR Optional
20 October, 2017 Interim report January - September 2017 News English Report Interim Q3 IR Optional
15 September, 2017 PledPharma’s CFO to leave the company in December 2017 News English IR Optional
30 August, 2017 Interim report January - June 2017 News English Report Interim Q2 IR Optional
17 August, 2017 PledPharma appoints a Chief Medical Officer News English IR Optional
25 April, 2017 Interim report January – March 2017 News English Report Interim Q1 IR Optional
6 April, 2017 PledPharma Appoints Nicklas Westerholm as New CEO News English IR Optional
24 February, 2017 Year end report January – December 2016 News English Report Interim Yearend IR Optional

Calendar and upcoming reports

May 3, 2024
Interim Report Q1 2024 (7:00am CEST)

May 6, 2024
Annual General Meeting

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com